Skip to main content
. Author manuscript; available in PMC: 2014 Sep 1.
Published in final edited form as: J Surg Res. 2013 Apr 5;184(1):290–298. doi: 10.1016/j.jss.2013.03.049

TABLE 1.

Cell Line Passage Median time to metastases N, (95% CI) Median Overall Survival N, (95% CI) Tumorigenicity
BxPC-3-RFP
 P0 12 weeks, (6.8, 17.2) 108 days, (59.7, 156.3) 8/13
 P6 3 weeks, (2.2, 3.8) 50 days, (42.3, 57.5) 10/10
Panc-1-GFP
 P0 14 weeks, (10.6, 17.4) 112 days, (63, 161) 4/8
 P5 4 weeks, (0.8, 7.2) 39 days, (26.2, 51.8) 5/5

CI = confidence interval.